599165-21-6

Basic information

• Product Name: 3β-tert-butyldimethylsilyl-1α-tert-butyldimethylsilyloxy-25-trimethylsilyloxy-19-norvitamin D₃
• Synonyms: 3β-tert-butyldimethylsilyl-1α-tert-butyldimethylsilyloxy-25-trimethylsilyloxy-19-norvitamin D₃
• CAS NO: 599165-21-6
• Molecular Weight: 717.352
• Mol File: 599165-21-6.mol

Chemical Properties

• CAS DataBase Reference: 3β-tert-butyldimethylsilyl-1α-tert-butyldimethylsilyloxy-25-trimethylsilyloxy-19-norvitamin D₃(CAS DataBase Reference)
• NIST Chemistry Reference: 3β-tert-butyldimethylsilyl-1α-tert-butyldimethylsilyloxy-25-trimethylsilyloxy-19-norvitamin D₃(599165-21-6)
• EPA Substance Registry System: 3β-tert-butyldimethylsilyl-1α-tert-butyldimethylsilyloxy-25-trimethylsilyloxy-19-norvitamin D₃(599165-21-6)

Safety Data

• Hazardous Substances Data: 599165-21-6(Hazardous Substances Data)

Upstream product

• 387834-49-3 (1R,3aS,7aR)-(E)-2-{1-[(R)-1,5-dimethyl-5-(trimethylsilanyloxy)hexyl]-7a-methyloctahydroinden-4-ylidenemethyl}-4,4,5,5-tetramethyl[1,3,2]dioxaborolane 
• 502495-26-3 (Z)-(3S,5R)-1-bromomethylene-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexane 
• 83685-49-8 (1R,3aR,4R,7aR)-1-((R)-1,5-Dimethyl-hex-4-enyl)-7a-methyl-octahydro-inden-4-ol 
• 81506-38-9 (R)-4-((1R,3aR,4R,7aR)-4-Acetoxy-7a-methyl-octahydro-inden-1-yl)-pentanoic acid ethyl ester 
• 81506-30-1 1-((1S,3aS,7aS)-1-tert-Butoxy-7a-methyl-octahydro-inden-4-yl)-ethanone 
• 81506-25-4 <3S-(1Z,3α,5β)>-2-<3,5-bis<<(1,1-dimethylethyl)dimethylsilyl>oxy>-2-methylenecyclohexylidene>-1-chloroethane 
• 502495-30-9 (Z)-(2S,3S,5R)-2-bromomethyl-1-[bromo(trimethylsilyl)methylene]-3,5-bis(tert-butyldimethylsilyloxy)cyclohexane 
• 502495-29-6 (Z)-(1S,2S,5R)-2-bromomethyl-3-[bromo(trimethylsilyl)methylene]-5-(tert-butyldimethylsilyloxy)cyclohexanol 
• 502495-28-5 acetic acid (S)-5-hydroxy-8-(trimethylsilyl)octa-2,7-diynyl ester 
• 502495-27-4 (S)-8-(trimethylsilyl)octa-2,7-diyne-1,5-diol 
• 161167-56-2 {(2S,3S)-3-[(R)-2-(tert-Butyl-dimethyl-silanyloxy)-5-trimethylsilanyl-pent-4-ynyl]-oxiranyl}-methanol 
• 161055-36-3 (2S,3R)-2-[(R)-2-(tert-Butyl-dimethyl-silanyloxy)-5-trimethylsilanyl-pent-4-ynyl]-3-iodomethyl-oxirane 
• 161055-39-6 (3S,5R)-5-(tert-butyldimethylsilyloxy)-8-(trimethylsilyl)oct-1-en-7-yn-3-ol 
• 161055-33-0 (S,E)-5-(tert-butyldimethylsilyloxy)-8-(trimethylsilyl)oct-2-en-7-yn-1-ol 

Downstream Products

• 32222-06-3 calcitriol 

Relevant articles and documents

Facile construction of the 7,8-olefin linkage in vitamin D3: A practical synthesis benefiting the vitamin D3 analog study

A facile procedure for construction of the 7,8-olefin linkage in vitamin D3 is described. Treatment of a mixture of A-ring phosphine oxide and CD-ring ketone in THF with lithium hexamethyldisilazide (LHMDS) at -20°C followed by gradual heating

Process for the synthesis of vitamin d compounds and intermediates for the synthesis of the compounds

An object of the present invention is to provide a process for synthesizing a vitamin D compound by simple procedures at lower costs. The present invention provides a process for preparing a vitamin D compound and an intermediate thereof, comprising the s

Efficient convergent synthesis of 1alpha,25-dihydroxyvitamin D3 and its analogues by Suzuki-Miyaura coupling.

[reaction: see text] 1alpha,25-Dihydroxyvitamin D(3) was synthesized by the Suzuki-Miyaura coupling of the A-ring intermediate 1, which was efficiently prepared from readily available 1,7-enyne 2, with the corresponding boronate compound of the C,D-ring portion. The method was applied to prepare des-C,D analogues of 1alpha,25-dihydroxyvitamin D(3).

New Convergent Synthesis of 1α,25-Dihydroxyvitamin D3 and Its Analogues by Suzuki-Miyaura Coupling between A-Ring and C,D-Ring Parts

A new convergent method for the synthesis of 1α,25 -dihydroxyvitamin D3 and its analogues has been developed that involves efficient preparation of the A-ring part 1a, (Z)-(3S,5R)-1-bromom-ethylene-3,5-bis(tert-butyldimethylsilyloxy) -2-methylenecyclohexane, starting from epichlorohydrin (4) and its Suzuki-Miyaura coupling reaction with the C,D-ring part 12. Thus, (R)-4 was converted to (3S,5R)-5-(tert-butyldimethylsilyloxy)-8-(trimethylsilyl)-oct-l-en-7-yn-3-ol (3a) through a ten-step reaction sequence in 49% overall yield. Compound 3a thus obtained was treated with a Ti(O-i-Pr)4/2 i-PrMgCl reagent and then with NBS to afford (Z)-(1S,2S,5R)-2-bromomethyl-3-[bromo-(trimethylsilyl)methylene] -5-(tert-butyldimethylsilyloxy)cyclohexanol (10a) in 51% yield, from which la was obtained in 87% yield by sequential treatment with TBSCl/imidazole, DBU, and Cs2CO3. The resulting A-ring intermediate 1a was reacted with alkenylboronate 12 in the presence of a PdCl2(dppf) catalyst to furnish 1α,25 -dihydroxyvitamin D3 in 82% yield after protodesilylation. Similarly, all of the other three possible stereoisomers of A-ring parts 1b, 1c, and 1d were prepared, from which 1-epi-, 3-epi-, and 1,3-di-epi-1α,25-dihydroxyvitamin D3 were synthesized by coupling with 12 in excellent yield, respectively. Starting from 1a and 1c, des-C,D-1α,25-dihydroxyvitamin D3 analogues, retiferol 13 and its 3-epi derivative, were also prepared, respectively.